Navigenics offers personalized genetic testing technology that gives individuals a view into their DNA and reveals genetic predispositions for important health conditions. The company aims to help people apply these insights to improve preventive health decisions. The new capital will enable Navigenics to continue research into the impact of genomics on preventive health care and to expand its clinical offerings. Navigenics also plans to integrate personal genomics into employer-sponsored preventive health and wellness programs. The company raised approximately $18M in a Series C financing to support these efforts. Navigenics is based in Foster City, California. Navigenics is a Redwood City, Calif.–based personal-genomics company that scans millions of single-nucleotide polymorphisms (SNPs) to generate a personalized genetics analysis. The company is taking pre-orders and plans to begin delivering genetic-test results in the first quarter of the following year, initially offering roughly 20 tests. Navigenics intends to store customers' gene profiles and provide carefully limited, medically validated test results for conditions that can be treated or prevented, while supplying raw genetic data to individuals upon request. Pricing discussed in the coverage places an initial registration fee around $2,500 for a year of service, with additional years likely priced at about $250. The company has raised a second funding round that brings total financing to more than $25 million and counts Kleiner Perkins, Sequoia and Mohr Davidow among its investors, with Google reportedly investing as well. Many operational details—specific tests, final pricing, and exact data-delivery formats—were not yet available in the articles.

Total raised

$18M

Funding rounds

2

Latest round

Series C

Latest activity

Feb 2010